Searched for
GENERIC DRUG GROWTH
Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
- Convening India's brightest minds: The Bharat Life Sciences Award’s Innovation Summit to spotlight life sciencesIndia sets its sights on becoming a frontrunner in innovation within the life sciences arena. The Bharat Life Sciences Award 2026 aims to h...
- ETMarkets Smart Talk | Time to rotate from expensive smallcaps to large caps? Saurabh Prasad weighs inIn an interaction with Kshitij Anand of ETMarkets, Saurabh Prasad, Head – Research Centre at Mirae Asset Sharekhan, said large caps are now...
- ETMarkets Smart Talk | Two-year market consolidation may set stage for next bull run: UTI AMC’s Ajay TyagiTyagi, however, remains cautious on pockets of the mid- and small-cap universe, where valuations are above long-term averages. He sees larg...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Widening waistline: India's big, fat obesity hotspots may not be just the biggest cities anymoreIndia sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...
- India's pharma sector must shift from cost competitiveness to innovation, global quality: ExpertsFor the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...
- Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjectorBiocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two stren...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- Stocks in news: Cochin Shipyard, Voltas, Patanjali Foods, and PhysicsWallahIndian stock markets experienced a range-bound week with minor losses for Sensex and Nifty. Analysts are watching four key factors that wil...
- Natco Pharma Q1 profit falls 57 pc to Rs 206.5 crNatco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalido...
- Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategyIndependence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...
- Drug formulations & biologicals keep India's pharma exports healthy in Q1During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...
- Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...
- Q1 Earnings Scorecard: Strong demand drives revenue, input costs hit profitsSustained market demand led to impressive revenue growth in the automotive and consumer goods sectors. In contrast, while the banking secto...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Global Market: European shares climb as earnings, US-Iran diplomacy lift sentimentEuropean stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...
- India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...
- Losing weight fast on GLP-1 drugs? Your hair could be the next thing to goDermatologists report increased hair loss among GLP-1 drug users experiencing rapid weight reduction. This side effect, often telogen efflu...
Load More
